Dolutegravir-Lamivudine as Dual Therapy in naïve HIV-Infected Patients With Documented M184V Mutation:A Pilot Study
Status:
Suspended
Trial end date:
2022-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the antiviral efficacy, safety and tolerability of
dual therapy with 3TC and DTG as initial therapy among naïve HIV patients with a documented
M184V mutation.